Katzenstein H - Search Results

1

Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 Neuroblastoma.

Kandula S, Prabhu RS, Nanda R, Switchenko JM, Cash T, Qayed M, Katzenstein H, Esiashvili N. Kandula S, et al. Among authors: katzenstein h. J Pediatr Hematol Oncol. 2015 Apr;37(3):175-80. doi: 10.1097/MPH.0000000000000264. J Pediatr Hematol Oncol. 2015. PMID: 25238225 Free PMC article. Clinical Trial.

2

Advances in the diagnosis and treatment of neuroblastoma.

Katzenstein HM, Cohn SL. Katzenstein HM, et al. Curr Opin Oncol. 1998 Jan;10(1):43-51. doi: 10.1097/00001622-199801000-00008. Curr Opin Oncol. 1998. PMID: 9466484 Review.

3

Antiangiogenic therapy inhibits human neuroblastoma growth.

Katzenstein HM, Salwen HR, Nguyen NN, Meitar D, Cohn SL. Katzenstein HM, et al. Med Pediatr Oncol. 2001 Jan;36(1):190-3. doi: 10.1002/1096-911X(20010101)36:1<190::AID-MPO1045>3.0.CO;2-I. Med Pediatr Oncol. 2001. PMID: 11464880

4

Novel therapeutic approaches in the treatment of children with hepatoblastoma.

Katzenstein HM, Rigsby C, Shaw PH, Mitchell TL, Haut PR, Kletzel M. Katzenstein HM, et al. J Pediatr Hematol Oncol. 2002 Dec;24(9):751-5. doi: 10.1097/00043426-200212000-00014. J Pediatr Hematol Oncol. 2002. PMID: 12468918

5

Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents.

Murphy SB, Morgan ER, Katzenstein HM, Kletzel M. Murphy SB, et al. J Pediatr Hematol Oncol. 2003 Sep;25(9):684-7. doi: 10.1097/00043426-200309000-00003. J Pediatr Hematol Oncol. 2003. PMID: 12972802

6

Anaplastic large cell neuroblastoma.

Abramowsky CR, Katzenstein HM, Alvarado CS, Shehata BM. Abramowsky CR, et al. Pediatr Dev Pathol. 2009 Jan-Feb;12(1):1-5. doi: 10.2350/07-04-0255.1. Pediatr Dev Pathol. 2009. PMID: 18397155

7

Intensity-modulated radiotherapy with use of cone-down boost for pediatric head-and-neck rhabdomyosarcoma.

McDonald MW, Esiashvili N, George BA, Katzenstein HM, Olson TA, Rapkin LB, Marcus RB Jr. McDonald MW, et al. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):884-91. doi: 10.1016/j.ijrobp.2008.01.058. Epub 2008 May 1. Int J Radiat Oncol Biol Phys. 2008. PMID: 18455321

8

Excellent local control from radiation therapy for high-risk neuroblastoma.

Gatcombe HG, Marcus RB Jr, Katzenstein HM, Tighiouart M, Esiashvili N. Gatcombe HG, et al. Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1549-54. doi: 10.1016/j.ijrobp.2008.10.069. Epub 2009 Feb 11. Int J Radiat Oncol Biol Phys. 2009. PMID: 19211198

9

Irinotecan as maintenance therapy in high-risk hepatoblastoma.

Qayed M, Powell C, Morgan ER, Haugen M, Katzenstein HM. Qayed M, et al. Pediatr Blood Cancer. 2010 May;54(5):761-3. doi: 10.1002/pbc.22408. Pediatr Blood Cancer. 2010. PMID: 20063426

10

Neuroblastoma.

Esiashvili N, Anderson C, Katzenstein HM. Esiashvili N, et al. Curr Probl Cancer. 2009 Nov-Dec;33(6):333-60. doi: 10.1016/j.currproblcancer.2009.12.001. Curr Probl Cancer. 2009. PMID: 20172369 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page